154 related articles for article (PubMed ID: 31096309)
1. Statin Therapy to Revert Hypercoagulability and Prevent Venous Thromboembolism: A Narrative Review.
Orsi FA; Cannegieter SC; Lijfering WM
Semin Thromb Hemost; 2019 Nov; 45(8):825-833. PubMed ID: 31096309
[TBL] [Abstract][Full Text] [Related]
2. Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial.
Orsi FA; Biedermann JS; Kruip MJHA; van der Meer FJ; Rosendaal FR; van Hylckama Vlieg A; Bos MHA; Leebeek FWG; Cannegieter SC; Lijfering WM
J Thromb Haemost; 2019 Feb; 17(2):319-328. PubMed ID: 30565854
[TBL] [Abstract][Full Text] [Related]
3. Statins and venous thromboembolism: do they represent a viable therapeutic agent?
Kunutsor SK; Whitehouse MR; Blom AW; Laukkanen JA
Expert Rev Cardiovasc Ther; 2017 Aug; 15(8):629-637. PubMed ID: 28724320
[TBL] [Abstract][Full Text] [Related]
4. [Statins can maybe reduce the risk of venous thromboembolism].
Toft-Petersen AP; Thomsen RW; Schmidt EB; Larsen TB
Ugeskr Laeger; 2011 May; 173(22):1558-63. PubMed ID: 21627898
[TBL] [Abstract][Full Text] [Related]
5. Rosuvastatin treatment decreases plasma procoagulant phospholipid activity after a VTE: A randomized controlled trial.
Ramberg C; Hindberg K; Biedermann JS; Cannegieter SC; van der Meer FJ; Snir O; Leebeek FWG; Kruip MJHA; Hansen JB; Lijfering WM
J Thromb Haemost; 2022 Apr; 20(4):877-887. PubMed ID: 34953155
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of Statins for Prevention of Venous Thromboembolism.
Chaffey P; Thompson M; Pai AD; Tafreshi AR; Tafreshi J; Pai RG
Am J Cardiol; 2018 Jun; 121(11):1436-1440. PubMed ID: 29576234
[TBL] [Abstract][Full Text] [Related]
7. Statins for the prevention of venous thromboembolism? a narrative review.
Sehdev A; Wanner N; Pendleton RC
Hosp Pract (1995); 2012 Aug; 40(3):13-8. PubMed ID: 23086090
[TBL] [Abstract][Full Text] [Related]
8. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
[TBL] [Abstract][Full Text] [Related]
9. Statins and prevention of venous thromboembolism: Myth or reality?
Gaertner S; Cordeanu EM; Nouri S; Mirea C; Stephan D
Arch Cardiovasc Dis; 2016 Mar; 109(3):216-22. PubMed ID: 26778087
[TBL] [Abstract][Full Text] [Related]
10. Is the lower risk of venous thromboembolism with statins related to low-density-lipoprotein reduction? A network meta-analysis and meta-regression of randomised controlled trials.
Zaccardi F; Kunutsor SK; Seidu S; Davies MJ; Khunti K
Atherosclerosis; 2018 Apr; 271():223-231. PubMed ID: 29524865
[TBL] [Abstract][Full Text] [Related]
11. Statins and primary prevention of venous thromboembolism: a systematic review and meta-analysis.
Kunutsor SK; Seidu S; Khunti K
Lancet Haematol; 2017 Feb; 4(2):e83-e93. PubMed ID: 28089655
[TBL] [Abstract][Full Text] [Related]
12. Statins in the prevention of venous thromboembolism: a meta-analysis of observational studies.
Pai M; Evans NS; Shah SJ; Green D; Cook D; Crowther MA
Thromb Res; 2011 Nov; 128(5):422-30. PubMed ID: 21641019
[TBL] [Abstract][Full Text] [Related]
13. Effect of Statins on Recurrent Venous Thromboembolism (from the COMMAND VTE Registry).
Yoshikawa Y; Yamashita Y; Morimoto T; Mabuchi H; Amano H; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Saga S; Nishimoto Y; Sasa T; Sakamoto J; Kinoshita M; Togi K; Takabayashi K; Shiomi H; Kato T; Makiyama T; Ono K; Murakami T; Kimura T;
Am J Cardiol; 2020 Jan; 125(2):189-197. PubMed ID: 31744599
[TBL] [Abstract][Full Text] [Related]
14. Statins and secondary prevention of venous thromboembolism: pooled analysis of published observational cohort studies.
Kunutsor SK; Seidu S; Khunti K
Eur Heart J; 2017 May; 38(20):1608-1612. PubMed ID: 28369602
[TBL] [Abstract][Full Text] [Related]
15. Statin use and the prevention of venous thromboembolism: a meta-analysis.
Agarwal V; Phung OJ; Tongbram V; Bhardwaj A; Coleman CI
Int J Clin Pract; 2010 Sep; 64(10):1375-83. PubMed ID: 20716146
[TBL] [Abstract][Full Text] [Related]
16. Effect of statins on the risk of recurrent venous thromboembolism: A systematic review and meta-analysis.
Li R; Yuan M; Yu S; Fu W; Yu W; Ling S; Sun J; Chen Y
Pharmacol Res; 2021 Mar; 165():105413. PubMed ID: 33412275
[TBL] [Abstract][Full Text] [Related]
17. Interpreting the JUPITER trial: statins can prevent VTE, but more study is needed.
Perez A; Bartholomew JR
Cleve Clin J Med; 2010 Mar; 77(3):191-4. PubMed ID: 20200169
[TBL] [Abstract][Full Text] [Related]
18. Statin therapy and levels of hemostatic factors in a healthy population: the Multi-Ethnic Study of Atherosclerosis.
Adams NB; Lutsey PL; Folsom AR; Herrington DH; Sibley CT; Zakai NA; Ades S; Burke GL; Cushman M
J Thromb Haemost; 2013 Jun; 11(6):1078-84. PubMed ID: 23565981
[TBL] [Abstract][Full Text] [Related]
19. Statin Use and the Risk of Venous Thromboembolism in Women Taking Hormone Therapy.
Davis JW; Weller SC; Porterfield L; Chen L; Wilkinson GS
JAMA Netw Open; 2023 Dec; 6(12):e2348213. PubMed ID: 38100102
[TBL] [Abstract][Full Text] [Related]
20. Statins and risk of thromboembolism: A meta-regression to disentangle the efficacy-to-effectiveness gap using observational and trial evidence.
Miksza JK; Zaccardi F; Kunutsor SK; Seidu S; Davies MJ; Khunti K
Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1023-1029. PubMed ID: 31383500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
